223
Participants
Start Date
June 3, 2024
Primary Completion Date
April 23, 2025
Study Completion Date
April 23, 2025
Test IOL Model DEN00V
Eligible subjects will be randomized in a 1:1 ratio to receive the Test IOL Model DEN00V in both eyes for the duration of the study
Control IOL Model DCB00
Eligible subjects will be randomized in a 1:1 ratio to receive the control IOL Model DCB00 in both eyes for the duration of the study
OCLI Vision, Garden City
Levenson Eye Associates, Jacksonville
Cleveland Eye Clinic, Brecksville
Jones Eye Center, Sioux City
Vance Thompson Vision, Sioux Falls
Berkeley Eye Center, Houston
Whitsett Vision Group, Houston
Parkhurst NuVision, San Antonio
Empire Eye & Laser Center, Bakersfield
Johnson & Johnson Surgical Vision, Inc.
INDUSTRY